Fludarabine, cytarabine, granulocyte colony‐stimulating factor and melphalan (FALG with L‐PAM) as a reduced toxicity conditioning regimen in children with acute leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|61|4|712-716

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.61, Iss.4, 2014-04, pp. : 712-716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of a fludarabine and melphalan combination‐based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 883-889

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cutaneous Eruptions Induced by Granulocyte Colony‐stimulating Factor in Two Cases of Acute Myelogenous Leukemia

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 8, 1993-08 ,pp. : 473-477

John Wiley & Sons Inc

Access to resources Recommend Favorite

Remission Induction by Granulocyte Colony-Stimulating Factor in Hypoplastic Acute Myelogenous Leukemia Complicated by Infection

By  

Acta Haematologica, Vol. 99, Iss. 4, 1998-05 ,pp. : 224-230

Karger

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor and leukemogenesis

By Lorena Lobo de Figueiredo   Rodrigo Siqueira de Abreu e Lima   Eduardo Magalhães Rego  

Mediators of Inflammation, Vol. 13, Iss. 3, 2004-06 ,pp. : 145-150

Informa Healthcare

Access to resources Recommend Favorite

Reduced‐intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1048-1055

John Wiley & Sons Inc

Access to resources Recommend Favorite